17312 Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Career 

Development Facilitating The Transition to 

Independence Study Section. 

Date: June 9–10, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging Gateway 

Building 7201 Wisconsin Avenue Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: NIJAGUNA PRASAD, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

7201 Wisconsin Avenue, Gateway Bldg, Suite 

2W200, Bethesda, MD 20892, (301) 496– 

9667, prasadnb@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: March 22, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–06372 Filed 3–25–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Digestive Diseases 

Research Core Centers (P30). 

Date: July 14–15, 2022. 

Time: 10:00 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIDDK, 6707 Democracy Blvd., Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, Review Branch, Division of 

Extramural Activities, NIDDK, National 

Institutes of Health, Room 7011, 6707 

Democracy Boulevard, Bethesda, MD 20892– 

5452, (301) 594–7799 yangj@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 22, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–06376 Filed 3–25–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Refugee Resettlement 

Extending Refugee Cash Assistance 

and Refugee Medical Assistance From 

8 Months to 12 Months 

AGENCY: Office of Refugee Resettlement 

(ORR), Administration for Children and 

Families (ACF), Department of Health 

and Human Services (HHS). 

ACTION: Notice of change of eligibility 

period. 

SUMMARY: In accordance with ORR 

regulations, the Director of ORR is 

announcing the expansion of the 

Refugee Cash Assistance (RCA) and 

Refugee Medical Assistance (RMA) 

eligibility period from 8 months to 12 

months of assistance for participants 

whose date of eligibility for ORR 

benefits is on or after October 1, 2021. 

Through the Refugee Act of 1980, 

Congress authorized cash and medical 

assistance up to 36 months, yet by fiscal 

year (FY) 1992, mainly due to 

insufficient appropriations, ORR had 

reduced the RCA and RMA eligibility 

periods to 8 months. For 30 years, ORR 

has not increased the RCA or RMA 

eligibility period. Extending the RCA 

and RMA eligibility period will lead to 

more effective resettlement, by 

providing refugee and other ORReligible populations with additional 

time to become self-sufficient. 

DATES: The changes described in this 

Federal Register notice are effective as 

of the date of publication. 

FOR FURTHER INFORMATION CONTACT: 

Colleen Mahar-Piersma, Refugee Policy 

Unit, Division of Policy and Procedures, 

Office of the Director, Office of Refugee 

Resettlement, Administration for 

Children and Families, by phone at 

(202) 260–5493, and email at 

refugeepolicy@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 1980 

Refugee Act (8 U.S.C. 1522(e)(1)) 

authorized the Director of ORR 

(hereinafter ‘‘the Director’’) to provide 

RCA and RMA during the first 36 

months after a refugee’s arrival in the 

United States or, for other ORR-eligible 

populations, after they became eligible 

for ORR benefits and services. (ORReligible populations, hereinafter referred 

to as ‘‘refugees,’’ are outlined within 

ORR Policy Letter (PL) 16–01, 

Documentation Requirements for the 

Refugee Resettlement Program and ORR 

PL 22–02, Additional ORR-Eligible 

Statuses and Categories and Acceptable 

Documentation Requirements for 

Afghan Nationals.) 

ORR regulations (45 CFR 400.211(a)) 

authorize the Director to determine the 

time-eligibility period for RCA and 

RMA each year based on the 

appropriated funds available for the 

fiscal year. After Congress passed the 

Refugee Act of 1980, ORR provided 

refugees with RCA and RMA for the first 

36 months after a refugee’s arrival. 

However, due to reduced 

appropriations, ORR had to decrease 

this assistance from 36 months to 18 

months, then to 12 months, and finally, 

in FY 1992, to 8 months. 

The proposed expansion of the RCA 

and RMA eligibility period would 

positively impact refugees who are not 

eligible for Temporary Assistance for 

Needy Families or Medicaid. Increasing 

the RCA and RMA eligibility period 

enables refugees to address any medical 

and mental health issues that would 

impede their ability to become selfsufficient. Additionally, an expanded 

eligibility period allows refugees to 

focus on the Congressional priorities for 

assistance, as outlined in the Refugee 

Act, of acquiring English, receiving 

employment training, and securing 

employment, with the increase in 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 59 / Monday, March 28, 2022 / Notices 17313 

English skills and professional 

development potentially facilitating 

employment at higher wagers, a benefit 

not only for their families but for every 

community where they reside. 

Refugees whose date of eligibility for 

ORR benefits is in FY 2022 (on or after 

October 1, 2021) are eligible for the 

expanded RCA and RMA eligibility 

period. 

(Authority: 45 CFR 400.211) 

Dated: March 22, 2022. 

Cindy Huang, 

Director of the Office of Refugee Resettlement. 

[FR Doc. 2022–06356 Filed 3–25–22; 8:45 am] 

BILLING CODE 4120–27–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer at (240) 276–0361. 

Project: Mental and Substance Use 

Disorders Prevalence Study (MDPS) 

Grant Funded by SAMHSA, Grant 

Number H79FG000030 

SAMHSA is requesting from the 

Office of Management and Budget 

(OMB) approval to conduct recruitment 

activities and clinical interviews with 

household respondents and nonhousehold facilities and respondents as 

part of the Mental and Substance Use 

Disorders Prevalence Study (MDPS) 

pilot program. Activities conducted will 

include: A household rostering and 

mental health screening of household 

participants and a clinical interview of 

both household and non-household 

participants. The information gathered 

by the clinical interview will be used to 

determine prevalence estimates of 

schizophrenia or schizoaffective 

disorder; bipolar I disorder; major 

depressive disorder; generalized anxiety 

disorder; posttraumatic stress disorder 

(PTSD); obsessive-compulsive disorder; 

anorexia nervosa; and alcohol, 

benzodiazepine, opioid, stimulant, and 

cannabis use disorders among U.S. 

adults ages 18 to 65 years. 

Household Rostering 

The household rostering includes 

inquiries about all adults ages 18 and 

older residing in the household, to 

assess eligibility for inclusion in the 

study, and then selecting up to two 

adults for the household mental health 

screening. The total number of 

household members and numbers of 

adults and children are first asked, 

followed by the first name, age and sex 

of all adult household members, as well 

as whether any adult in the household 

has had a serious medical condition. 

The best time to be interviewed is 

collected as well. The computerized 

roster can be completed online, by 

phone, on paper, or in-person. The 

target population is adults ages 18–65 

residing in U.S. households; it is 

estimated that 45,000 household rosters 

will be completed. The primary 

objective of the household roster is to 

select up to two age-eligible participants 

for the mental health screening 

interview. 

Household Mental Health Screening 

The household mental health 

screening interview utilizes the 

Computerized Adaptive Testing for 

Mental Health Disorders (CAT–MH) or 

the World Health Organization’s 

Composite International Diagnostic 

Interview (CIDI) instruments to assess 

symptoms related to the mental health 

and substance use disorders of interest, 

including schizophrenia or 

schizoaffective disorder; bipolar I 

disorder; major depressive disorder; 

generalized anxiety disorder; 

posttraumatic stress disorder (PTSD); 

obsessive-compulsive disorder; anorexia 

nervosa; and alcohol, benzodiazepine, 

opioid, stimulant, and cannabis use. 

The screening instrument also includes 

questions on treatment, receipt of Social 

Security Disability Income (SSDI), 

military experience, and exposure to 

and impact of COVID–19. The 

computerized mental health screening 

can be completed online, by phone, on 

paper or in-person. The primary 

objectives of the household mental 

health screening interview are to assess 

the symptoms endorsed and determine 

eligibility and selection for the MDPS 

pilot program clinical interview. 

Clinical Interview 

The MDPS pilot program clinical 

interview includes questions that assess 

the mental health and substance use 

disorders using the NetSCID, a 

computerized version of the Structured 

Clinical Interview for DSM–V (SCID). 

This instrument includes questions on 

symptoms and their duration and 

frequency for the disorders of interest. 

Also collected from respondents is 

demographic information, including 

sex, gender, age, education and 

employment status. Hospitalization and 

treatment history are asked as well as 

questions to assess exposure to COVID– 

19 of self or other close family members 

and the impact on mental health. Up to 

two adults per household will be 

selected to complete the clinical 

interview. Participants from the prisons, 

jails, homeless shelters and state 

psychiatric hospitals will complete the 

clinical interview as well. The 

computer-assisted personal interview 

(CAPI) is administered by a trained 

clinical interviewer, and can be 

conducted by video conference, such as 

Zoom or WebEx, phone or in person. 

Approximately 7,200 clinical interviews 

will be conducted as part of the MDPS 

pilot program. The primary objective of 

the clinical interview is to estimate the 

prevalence of the disorders of interest, 

including schizophrenia or 

schizoaffective disorder; bipolar I 

disorder; major depressive disorder; 

generalized anxiety disorder; 

posttraumatic stress disorder (PTSD); 

obsessive-compulsive disorder; anorexia 

nervosa; and alcohol, benzodiazepine, 

opioid, stimulant, and cannabis use, as 

well as unmet treatment needs. 

Jail Mental Health Screening 

The jail mental health screening 

interview utilizes the CIDI screening 

instruments to assess symptoms related 

to the primary mental health and 

substance use disorders of interest 

including schizophrenia or 

schizoaffective disorder; bipolar I 

disorder; major depressive disorder; 

generalized anxiety disorder; 

posttraumatic stress disorder (PTSD); 

obsessive-compulsive disorder; anorexia 

nervosa; and alcohol, benzodiazepine, 

opioid, stimulant, and cannabis use. 

The screening instrument also includes 

questions on treatment, receipt of Social 

Security Disability Income (SSDI), 

military experience, and exposure to 

and impact of COVID–19. The 

computerized mental health screening 

will be completed in person or by 

phone. The target population is a 

convenience sample of incarcerated 18– 

65-year-old adults, in up to six jails 

identified by the MDPS co-investigator 

team. Up to 208 mental health screening 

interviews will be conducted among 

incarcerated respondents. Respondents 

will be provided with a card that 

includes contact information and asked 

to contact the project personnel when 

they are released for inclusion in the 

household clinical interview sample. 

The primary objective of the jail mental 


jspears on DSK121TN23PROD with NOTICES1